Grindel J M, Migdalof B H, Cressman W A
Drug Metab Dispos. 1979 Sep-Oct;7(5):325-9.
Penfluridol, 1-[4,4-bis(4-fluorophenyl)butyl]-4-[4-chloro-3-(trifluoromethyl)phenyl]-4-piperidinol, was well absorbed by the rat, rabbit, dog, and man after single oral doses of drug in solution. Penfluridol and its metabolites were widely distributed in tissues of male rats and cleared slowly. The terminal plasma t 1/2 for penfluridol was greater than 40 hr for the rabbit, 227 hr for the dog, and 199 hr for man. Fecal excretion of total radioactivity predominated in the rat, rabbit, and dog whereas in man excretion was evenly divided between urine and feces. The major biotransformation pathways of penfluridol in the rat, rabbit, dog, and man were oxidative N-dealkylation followed by beta-oxidation, conjugation of penfluridol, and conjugation of the acidic metabolites.
五氟利多,1-[4,4-双(4-氟苯基)丁基]-4-[4-氯-3-(三氟甲基)苯基]-4-哌啶醇,大鼠、兔、犬和人单次口服溶液剂药物后吸收良好。五氟利多及其代谢产物在雄性大鼠组织中广泛分布且清除缓慢。五氟利多在兔体内的终末血浆半衰期大于40小时,在犬体内为227小时,在人体内为199小时。大鼠、兔和犬粪便中总放射性排泄占主导,而在人体内,尿液和粪便排泄量相当。五氟利多在大鼠、兔、犬和人体内的主要生物转化途径是氧化N-去烷基化,随后是β-氧化、五氟利多的结合以及酸性代谢产物的结合。